25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Bionano Genomics Inc
Buy, Hold or Sell?

Let's analyze Bionano together

I guess you are interested in Bionano Genomics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Bionano Genomics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Bionano Genomics Inc

I send you an email if I find something interesting about Bionano Genomics Inc.

1. Quick Overview

1.1. Quick analysis of Bionano (30 sec.)










1.2. What can you expect buying and holding a share of Bionano? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.48
Expected worth in 1 year
$-0.21
How sure are you?
18.8%

+ What do you gain per year?

Total Gains per Share
$-0.69
Return On Investment
-287.8%

For what price can you sell your share?

Current Price per Share
$0.24
Expected price per share
$0.2 - $0.376
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Bionano (5 min.)




Live pricePrice per Share (EOD)
$0.24
Intrinsic Value Per Share
$-5.41 - $-6.01
Total Value Per Share
$-4.93 - $-5.53

2.2. Growth of Bionano (5 min.)




Is Bionano growing?

Current yearPrevious yearGrowGrow %
How rich?$48.8m$203.6m-$126.6m-164.4%

How much money is Bionano making?

Current yearPrevious yearGrowGrow %
Making money-$33.9m-$56.8m$22.8m67.4%
Net Profit Margin-426.3%-657.2%--

How much money comes from the company's main activities?

2.3. Financial Health of Bionano (5 min.)




2.4. Comparing to competitors in the Medical Instruments & Supplies industry (5 min.)




  Industry Rankings (Medical Instruments & Supplies)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Bionano?

Welcome investor! Bionano's management wants to use your money to grow the business. In return you get a share of Bionano.

First you should know what it really means to hold a share of Bionano. And how you can make/lose money.

Speculation

The Price per Share of Bionano is $0.2389. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Bionano.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Bionano, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.48. Based on the TTM, the Book Value Change Per Share is $-0.17 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.40 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Bionano.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.43-181.6%-0.33-139.3%-0.56-233.2%-0.28-118.7%-0.20-84.8%
Usd Book Value Change Per Share-0.31-129.2%-0.17-72.0%-0.40-167.0%0.0311.5%0.016.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.31-129.2%-0.17-72.0%-0.40-167.0%0.0311.5%0.016.3%
Usd Price Per Share0.45-1.03-1.55-2.30-2.08-
Price to Earnings Ratio-0.26--0.83--0.70--3.33--4.81-
Price-to-Total Gains Ratio-1.47--11.69--4.47--17.48--23.77-
Price to Book Ratio0.95-1.30-0.99-3.25-1.59-
Price-to-Total Gains Ratio-1.47--11.69--4.47--17.48--23.77-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.2389
Number of shares4185
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.170.03
Usd Total Gains Per Share-0.170.03
Gains per Quarter (4185 shares)-719.41115.40
Gains per Year (4185 shares)-2,877.63461.58
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-2878-28880462452
20-5755-57660923914
30-8633-8644013851376
40-11511-11522018461838
50-14388-14400023082300
60-17266-17278027702762
70-20143-20156032313224
80-23021-23034036933686
90-25899-25912041544148
100-28776-28790046164610

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%1.031.00.03.1%1.031.00.03.1%
Book Value Change Per Share0.04.00.00.0%0.012.00.00.0%5.015.00.025.0%6.023.03.018.8%6.023.03.018.8%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.032.00.0%0.00.032.00.0%
Total Gains per Share0.04.00.00.0%0.012.00.00.0%5.015.00.025.0%6.023.03.018.8%6.023.03.018.8%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Bionano Genomics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.309-0.172-44%-0.399+29%0.028-1219%0.015-2161%
Book Value Per Share--0.4790.755-37%1.997-76%1.688-72%1.010-53%
Current Ratio--1.4261.480-4%3.595-60%8.617-83%6.154-77%
Debt To Asset Ratio--0.4410.462-5%0.238+85%0.367+20%0.955-54%
Debt To Equity Ratio--0.7880.884-11%0.322+145%0.953-17%0.799-1%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value--30754622.70084245469.175-63%186179132.500-83%317004091.385-90%337171982.016-91%
Eps---0.434-0.333-23%-0.557+28%-0.284-35%-0.203-53%
Ev To Ebitda Ratio---0.175-0.748+327%-1.357+675%-4.611+2533%-7.150+3982%
Ev To Sales Ratio--1.2662.306-45%5.476-77%17.783-93%22.101-94%
Free Cash Flow Per Share---0.130-0.239+83%-0.325+149%-0.215+65%-0.161+23%
Free Cash Flow To Equity Per Share---0.071-0.103+45%-0.213+198%0.050-243%0.032-321%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---6.013--------
Intrinsic Value_10Y_min---5.407--------
Intrinsic Value_1Y_max---1.064--------
Intrinsic Value_1Y_min---1.045--------
Intrinsic Value_3Y_max---2.844--------
Intrinsic Value_3Y_min---2.722--------
Intrinsic Value_5Y_max---4.201--------
Intrinsic Value_5Y_min---3.930--------
Market Cap24366127.700-90%46294622.700105356219.175-56%158344132.500-71%234415101.585-80%212591021.919-78%
Net Profit Margin---7.286-4.263-41%-6.572-10%-5.035-31%-4.061-44%
Operating Margin----2.3100%-4.4800%-4.1960%-3.5420%
Operating Ratio--8.2294.595+79%5.514+49%5.433+51%4.679+76%
Pb Ratio0.499-90%0.9471.295-27%0.993-5%3.248-71%1.593-41%
Pe Ratio-0.138+47%-0.262-0.831+218%-0.703+169%-3.329+1173%-4.807+1738%
Price Per Share0.239-90%0.4541.033-56%1.553-71%2.298-80%2.084-78%
Price To Free Cash Flow Ratio-0.458+47%-0.870-1.018+17%-1.311+51%-3.604+314%-5.207+499%
Price To Total Gains Ratio-0.774+47%-1.471-11.695+695%-4.468+204%-17.484+1089%-23.774+1516%
Quick Ratio--1.2881.369-6%4.590-72%10.496-88%7.194-82%
Return On Assets---0.506-0.259-49%-0.254-50%-0.205-60%-0.277-45%
Return On Equity---0.905-0.486-46%-0.361-60%-0.428-53%-0.339-63%
Total Gains Per Share---0.309-0.172-44%-0.399+29%0.028-1219%0.015-2161%
Usd Book Value--48868000.00077033250.000-37%203660000.000-76%172132555.250-72%103008678.031-53%
Usd Book Value Change Per Share---0.309-0.172-44%-0.399+29%0.028-1219%0.015-2161%
Usd Book Value Per Share--0.4790.755-37%1.997-76%1.688-72%1.010-53%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.434-0.333-23%-0.557+28%-0.284-35%-0.203-53%
Usd Free Cash Flow---13309000.000-24391500.000+83%-33106500.000+149%-21929207.200+65%-16425789.719+23%
Usd Free Cash Flow Per Share---0.130-0.239+83%-0.325+149%-0.215+65%-0.161+23%
Usd Free Cash Flow To Equity Per Share---0.071-0.103+45%-0.213+198%0.050-243%0.032-321%
Usd Market Cap24366127.700-90%46294622.700105356219.175-56%158344132.500-71%234415101.585-80%212591021.919-78%
Usd Price Per Share0.239-90%0.4541.033-56%1.553-71%2.298-80%2.084-78%
Usd Profit---44246000.000-33945750.000-23%-56819750.000+28%-28921157.800-35%-20657750.094-53%
Usd Revenue--6073000.0008333500.000-27%8402500.000-28%5790237.800+5%4732622.250+28%
Usd Total Gains Per Share---0.309-0.172-44%-0.399+29%0.028-1219%0.015-2161%
 EOD+3 -5MRQTTM+11 -24YOY+16 -195Y+9 -2710Y+10 -26

3.3 Fundamental Score

Let's check the fundamental score of Bionano Genomics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.138
Price to Book Ratio (EOD)Between0-10.499
Net Profit Margin (MRQ)Greater than0-7.286
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.288
Current Ratio (MRQ)Greater than11.426
Debt to Asset Ratio (MRQ)Less than10.441
Debt to Equity Ratio (MRQ)Less than10.788
Return on Equity (MRQ)Greater than0.15-0.905
Return on Assets (MRQ)Greater than0.05-0.506
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of Bionano Genomics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5040.213
Ma 20Greater thanMa 500.251
Ma 50Greater thanMa 1000.317
Ma 100Greater thanMa 2000.412
OpenGreater thanClose0.245
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Bionano Genomics Inc

Bionano Genomics, Inc. provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA. The company also provides Saphyr and Bionano compute servers; and VIA software, which offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, it offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; OGM-Dx HemeOne testing; OGM-Dx FSHD, a test for individuals suspected of having FSHD type 1; and OGM-Dx Postnatal Whole Genome SV and OGM-Dx Prenatal Whole Genome SV for comprehensive testing. Bionano Genomics, Inc. was founded in 2003 and is headquartered in San Diego, California.

Fundamental data was last updated by Penke on 2024-12-05 14:26:06.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Bionano earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Bionano to the Medical Instruments & Supplies industry mean.
  • A Net Profit Margin of -728.6% means that $-7.29 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Bionano Genomics Inc:

  • The MRQ is -728.6%. The company is making a huge loss. -2
  • The TTM is -426.3%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-728.6%TTM-426.3%-302.3%
TTM-426.3%YOY-657.2%+230.9%
TTM-426.3%5Y-503.5%+77.3%
5Y-503.5%10Y-406.1%-97.5%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-728.6%5.5%-734.1%
TTM-426.3%4.7%-431.0%
YOY-657.2%7.3%-664.5%
5Y-503.5%7.1%-510.6%
10Y-406.1%7.6%-413.7%
4.3.1.2. Return on Assets

Shows how efficient Bionano is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Bionano to the Medical Instruments & Supplies industry mean.
  • -50.6% Return on Assets means that Bionano generated $-0.51 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Bionano Genomics Inc:

  • The MRQ is -50.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -25.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-50.6%TTM-25.9%-24.8%
TTM-25.9%YOY-25.4%-0.5%
TTM-25.9%5Y-20.5%-5.4%
5Y-20.5%10Y-27.7%+7.2%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-50.6%0.9%-51.5%
TTM-25.9%0.8%-26.7%
YOY-25.4%1.5%-26.9%
5Y-20.5%1.6%-22.1%
10Y-27.7%1.6%-29.3%
4.3.1.3. Return on Equity

Shows how efficient Bionano is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Bionano to the Medical Instruments & Supplies industry mean.
  • -90.5% Return on Equity means Bionano generated $-0.91 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Bionano Genomics Inc:

  • The MRQ is -90.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -48.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-90.5%TTM-48.6%-42.0%
TTM-48.6%YOY-36.1%-12.5%
TTM-48.6%5Y-42.8%-5.8%
5Y-42.8%10Y-33.9%-8.9%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-90.5%1.9%-92.4%
TTM-48.6%1.4%-50.0%
YOY-36.1%2.7%-38.8%
5Y-42.8%3.1%-45.9%
10Y-33.9%3.0%-36.9%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Bionano Genomics Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Bionano is operating .

  • Measures how much profit Bionano makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Bionano to the Medical Instruments & Supplies industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Bionano Genomics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-231.0%+231.0%
TTM-231.0%YOY-448.0%+217.1%
TTM-231.0%5Y-419.6%+188.6%
5Y-419.6%10Y-354.2%-65.4%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-8.8%-8.8%
TTM-231.0%5.2%-236.2%
YOY-448.0%10.7%-458.7%
5Y-419.6%9.7%-429.3%
10Y-354.2%9.1%-363.3%
4.3.2.2. Operating Ratio

Measures how efficient Bionano is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • An Operation Ratio of 8.23 means that the operating costs are $8.23 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Bionano Genomics Inc:

  • The MRQ is 8.229. The company is inefficient in keeping operating costs low. -1
  • The TTM is 4.595. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ8.229TTM4.595+3.634
TTM4.595YOY5.514-0.919
TTM4.5955Y5.433-0.838
5Y5.43310Y4.679+0.754
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ8.2291.047+7.182
TTM4.5951.059+3.536
YOY5.5141.001+4.513
5Y5.4331.047+4.386
10Y4.6791.006+3.673
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Bionano Genomics Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Bionano is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A Current Ratio of 1.43 means the company has $1.43 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Bionano Genomics Inc:

  • The MRQ is 1.426. The company is just able to pay all its short-term debts.
  • The TTM is 1.480. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.426TTM1.480-0.054
TTM1.480YOY3.595-2.116
TTM1.4805Y8.617-7.138
5Y8.61710Y6.154+2.463
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4262.117-0.691
TTM1.4802.286-0.806
YOY3.5952.506+1.089
5Y8.6172.652+5.965
10Y6.1542.636+3.518
4.4.3.2. Quick Ratio

Measures if Bionano is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Bionano to the Medical Instruments & Supplies industry mean.
  • A Quick Ratio of 1.29 means the company can pay off $1.29 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Bionano Genomics Inc:

  • The MRQ is 1.288. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 1.369. The company is able to pay all its short-term debts with the most liquid assets. +1
Trends
Current periodCompared to+/- 
MRQ1.288TTM1.369-0.081
TTM1.369YOY4.590-3.222
TTM1.3695Y10.496-9.127
5Y10.49610Y7.194+3.301
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2881.063+0.225
TTM1.3691.159+0.210
YOY4.5901.235+3.355
5Y10.4961.483+9.013
10Y7.1941.634+5.560
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Bionano Genomics Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Bionano assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Bionano to Medical Instruments & Supplies industry mean.
  • A Debt to Asset Ratio of 0.44 means that Bionano assets are financed with 44.1% credit (debt) and the remaining percentage (100% - 44.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Bionano Genomics Inc:

  • The MRQ is 0.441. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.462. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.441TTM0.462-0.021
TTM0.462YOY0.238+0.224
TTM0.4625Y0.367+0.094
5Y0.36710Y0.955-0.588
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4410.371+0.070
TTM0.4620.362+0.100
YOY0.2380.344-0.106
5Y0.3670.366+0.001
10Y0.9550.376+0.579
4.5.4.2. Debt to Equity Ratio

Measures if Bionano is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Bionano to the Medical Instruments & Supplies industry mean.
  • A Debt to Equity ratio of 78.8% means that company has $0.79 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Bionano Genomics Inc:

  • The MRQ is 0.788. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.884. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.788TTM0.884-0.096
TTM0.884YOY0.322+0.562
TTM0.8845Y0.953-0.069
5Y0.95310Y0.799+0.154
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7880.560+0.228
TTM0.8840.563+0.321
YOY0.3220.525-0.203
5Y0.9530.599+0.354
10Y0.7990.658+0.141
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Bionano generates.

  • Above 15 is considered overpriced but always compare Bionano to the Medical Instruments & Supplies industry mean.
  • A PE ratio of -0.26 means the investor is paying $-0.26 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Bionano Genomics Inc:

  • The EOD is -0.138. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.262. Based on the earnings, the company is expensive. -2
  • The TTM is -0.831. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.138MRQ-0.262+0.124
MRQ-0.262TTM-0.831+0.570
TTM-0.831YOY-0.703-0.129
TTM-0.8315Y-3.329+2.498
5Y-3.32910Y-4.807+1.478
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD-0.13815.764-15.902
MRQ-0.26215.891-16.153
TTM-0.83115.959-16.790
YOY-0.70319.991-20.694
5Y-3.32922.074-25.403
10Y-4.80723.677-28.484
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Bionano Genomics Inc:

  • The EOD is -0.458. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.870. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.018. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.458MRQ-0.870+0.412
MRQ-0.870TTM-1.018+0.148
TTM-1.018YOY-1.311+0.293
TTM-1.0185Y-3.604+2.587
5Y-3.60410Y-5.207+1.602
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD-0.45811.457-11.915
MRQ-0.87013.479-14.349
TTM-1.0189.150-10.168
YOY-1.311-0.045-1.266
5Y-3.6042.940-6.544
10Y-5.207-1.176-4.031
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Bionano is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A PB ratio of 0.95 means the investor is paying $0.95 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Bionano Genomics Inc:

  • The EOD is 0.499. Based on the equity, the company is cheap. +2
  • The MRQ is 0.947. Based on the equity, the company is cheap. +2
  • The TTM is 1.295. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.499MRQ0.947-0.449
MRQ0.947TTM1.295-0.348
TTM1.295YOY0.993+0.302
TTM1.2955Y3.248-1.952
5Y3.24810Y1.593+1.655
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD0.4992.602-2.103
MRQ0.9472.558-1.611
TTM1.2952.787-1.492
YOY0.9932.778-1.785
5Y3.2483.948-0.700
10Y1.5934.397-2.804
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Bionano Genomics Inc.

4.8.1. Institutions holding Bionano Genomics Inc

Institutions are holding 12.81% of the shares of Bionano Genomics Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-09-30Vanguard Group Inc2.1496021924921024954.9041
2024-09-30Geode Capital Management, LLC0.8656088285428363947.3351
2024-06-30BlackRock Inc0.5958060767922232957.6953
2024-09-30GMT Capital Corp0.51990.009653026000
2024-09-30Citadel Advisors Llc0.2442024907024906924906900
2024-09-30Northern Trust Corp0.1443014713400
2024-09-30TWO SIGMA SECURITIES, LLC0.13990.00111426441426440
2024-09-30State Street Corp0.1118011398800
2024-09-30GSA Capital Partners LLP0.09850.00351004141004140
2024-09-30Carret & Company Inc0.08340.0042850554005589.0111
2024-09-30T. Rowe Price Associates, Inc.0.06907037000
2024-09-30Archford Capital Strategies, LLC0.06820.00376956400
2024-09-30Susquehanna International Group, LLP0.04820491767651.5802
2024-06-30Jane Street Group LLC0.0475048485-20159-29.3675
2024-09-30Inspire Advisors, LLC0.03650.002137277-2399-6.0465
2024-09-30Golden State Equity Partners0.0260.00192650200
2024-09-30Morgan Stanley - Brokerage Accounts0.0252025707-36731-58.828
2024-09-30Two Sigma Investments LLC0.0232023678236780
2024-09-30Raymond James Finl Svs Advisors, Inc.0.019201957110685.772
2024-09-30Tower Research Capital LLC0.01670.000217040-8741-33.9048
Total 5.33270.02635438960+1098126+20.2%

4.9.2. Funds holding Bionano Genomics Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-10-31Vanguard Total Stock Mkt Idx Inv1.33780136443800
2024-10-31Vanguard Institutional Extnd Mkt Idx Tr0.49540.000150529200
2024-09-30Fidelity Extended Market Index0.49330.000650309212826734.2205
2024-10-31Vanguard Health Care ETF0.30560.0004311665-704-0.2254
2024-09-30BlackRock Extended Equity Market K0.190.0006193764-82-0.0423
2024-09-30Fidelity Total Market Index0.16350.000116679085949106.3186
2024-09-30Fidelity Series Total Market Index0.11410.000111633164983126.5541
2024-09-30T. Rowe Price U.S. Equities Tr0.0690.00037037000
2024-09-30Northern Trust Extended Eq Market Idx0.06890.00047024900
2024-09-30NT Ext Equity Mkt Idx Fd - L0.06890.00047024900
2024-09-30Spartan Extended Market Index Pool E0.05260.00065363815082.8928
2024-09-30NT Ext Equity Mkt Idx Fd - NL0.040.00034081300
2024-09-30NT Ext Equity Mkt Idx Fd - DC - NL - T20.03220.0003328831000.305
2024-09-30Spartan Total Market Index Pool E0.026602717500
2024-09-30Extended Equity Market Fund M0.02410.000624587-61-0.2475
2024-09-30Fidelity Nasdaq Composite Index0.015301556900
2024-10-31State St US Extended Mkt Indx NL Cl C0.0120.00021228900
2024-09-30NT Ext Eq Mkt Indx Fd DC Lending Tier 50.01060.000410840180.1663
2024-10-31Vanguard U.S. Eq Idx ÂŁ Acc0.010201039300
2024-09-30BlackRock U.S. Equity Market F0.008608738-1-0.0114
Total 3.53870.00543609165+279977+7.8%

5.3. Insider Transactions

Insiders are holding 0.153% of the shares of Bionano Genomics Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-06-13Hannah MamuszkaBUY65787.6
2023-05-16R. Erik HolmlinBUY15006.4
2023-05-12Christopher P StewartBUY50006.7
2022-08-15Yvonne LinneySELL200036.2
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-09-302023-12-312024-03-312024-06-302024-09-30
Gross Profit  2,749-3112,4383862,824-2392,585-11,031-8,446



5.2. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets87,362
Total Liabilities38,494
Total Stockholder Equity48,868
 As reported
Total Liabilities 38,494
Total Stockholder Equity+ 48,868
Total Assets = 87,362

Assets

Total Assets87,362
Total Current Assets46,980
Long-term Assets40,382
Total Current Assets
Cash And Cash Equivalents 8,794
Short-term Investments 14,160
Net Receivables 5,316
Inventory 14,323
Other Current Assets 4,387
Total Current Assets  (as reported)46,980
Total Current Assets  (calculated)46,980
+/-0
Long-term Assets
Property Plant Equipment 26,179
Intangible Assets 11,045
Long-term Assets Other 3,158
Long-term Assets  (as reported)40,382
Long-term Assets  (calculated)40,382
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities32,950
Long-term Liabilities5,544
Total Stockholder Equity48,868
Total Current Liabilities
Short-term Debt 17,172
Short Long Term Debt 14,953
Accounts payable 8,700
Other Current Liabilities 6,070
Total Current Liabilities  (as reported)32,950
Total Current Liabilities  (calculated)46,895
+/- 13,945
Long-term Liabilities
Capital Lease Obligations 7,500
Long-term Liabilities  (as reported)5,544
Long-term Liabilities  (calculated)7,500
+/- 1,956
Total Stockholder Equity
Common Stock9
Retained Earnings -673,100
Accumulated Other Comprehensive Income 1,534
Other Stockholders Equity 720,425
Total Stockholder Equity (as reported)48,868
Total Stockholder Equity (calculated)48,868
+/-0
Other
Capital Stock9
Cash and Short Term Investments 22,954
Common Stock Shares Outstanding 85,870
Liabilities and Stockholders Equity 87,362
Net Debt 13,659
Net Invested Capital 63,821
Net Working Capital 14,030
Property Plant and Equipment Gross 26,179
Short Long Term Debt Total 22,453



5.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-31
> Total Assets 
14,788
0
0
0
10,145
16,462
18,094
30,670
24,802
29,551
25,211
19,207
30,208
19,102
27,204
41,396
60,450
384,861
356,809
359,657
377,100
348,211
321,552
323,698
307,502
292,151
271,381
181,904
214,404
157,995
129,364
87,362
87,362129,364157,995214,404181,904271,381292,151307,502323,698321,552348,211377,100359,657356,809384,86160,45041,39627,20419,10230,20819,20725,21129,55124,80230,67018,09416,46210,14500014,788
   > Total Current Assets 
10,736
0
0
0
7,139
13,848
15,654
28,621
23,025
28,014
23,932
17,839
28,258
16,982
24,654
29,240
46,789
370,251
341,965
342,047
272,414
242,360
216,288
218,197
157,298
142,557
122,575
104,537
140,118
85,611
60,568
46,980
46,98060,56885,611140,118104,537122,575142,557157,298218,197216,288242,360272,414342,047341,965370,25146,78929,24024,65416,98228,25817,83923,93228,01423,02528,62115,65413,8487,13900010,736
       Cash And Cash Equivalents 
5,250
0
0
0
1,022
7,553
7,624
20,657
16,523
20,830
15,295
8,225
17,311
8,144
17,194
18,867
38,449
362,057
332,554
140,736
24,571
24,048
27,159
28,166
5,091
4,104
14,856
34,568
53,065
15,759
21,433
8,794
8,79421,43315,75953,06534,56814,8564,1045,09128,16627,15924,04824,571140,736332,554362,05738,44918,86717,1948,14417,3118,22515,29520,83016,52320,6577,6247,5531,0220005,250
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
185,333
226,041
192,420
160,178
152,024
108,095
91,704
62,206
29,014
48,823
37,007
8,516
14,160
14,1608,51637,00748,82329,01462,20691,704108,095152,024160,178192,420226,041185,3330000000000000000000
       Net Receivables 
1,847
0
0
0
3,352
2,536
2,886
4,001
4,514
4,057
4,984
6,001
6,334
4,115
3,249
3,860
2,775
1,992
2,838
2,996
4,934
5,514
4,851
5,829
7,022
6,780
7,613
8,669
9,661
8,313
6,255
5,316
5,3166,2558,3139,6618,6697,6136,7807,0225,8294,8515,5144,9342,9962,8381,9922,7753,8603,2494,1156,3346,0014,9844,0574,5144,0012,8862,5363,3520001,847
       Inventory 
1,797
0
0
0
1,694
2,014
1,973
2,615
1,069
1,406
3,022
2,595
3,444
3,611
3,290
4,593
3,316
3,036
4,890
9,020
12,387
16,268
20,591
25,046
29,761
33,113
32,453
26,429
22,893
19,587
19,475
14,323
14,32319,47519,58722,89326,42932,45333,11329,76125,04620,59116,26812,3879,0204,8903,0363,3164,5933,2903,6113,4442,5953,0221,4061,0692,6151,9732,0141,6940001,797
       Other Current Assets 
1,842
0
0
0
579
536
615
1,099
920
1,374
466
695
1,169
1,112
921
1,920
2,250
3,166
1,683
3,962
4,481
4,110
3,509
7,132
7,329
6,856
5,447
5,857
5,677
4,945
15,897
4,387
4,38715,8974,9455,6775,8575,4476,8567,3297,1323,5094,1104,4813,9621,6833,1662,2501,9209211,1121,1696954661,3749201,0996155365790001,842
   > Long-term Assets 
0
0
0
0
3,006
2,614
2,441
2,049
1,777
1,537
1,279
1,368
1,950
2,120
2,550
12,156
13,660
14,610
14,844
17,610
104,686
105,851
105,264
105,501
150,204
149,594
148,806
77,367
74,286
72,384
68,796
40,382
40,38268,79672,38474,28677,367148,806149,594150,204105,501105,264105,851104,68617,61014,84414,61013,66012,1562,5502,1201,9501,3681,2791,5371,7772,0492,4412,6143,0060000
       Property Plant Equipment 
4,052
0
0
0
3,006
2,614
2,441
2,049
1,777
1,537
1,279
1,368
1,950
2,120
2,550
3,635
4,910
5,806
6,084
8,554
20,935
23,375
24,164
25,648
28,958
29,769
30,566
30,991
32,481
33,602
32,486
26,179
26,17932,48633,60232,48130,99130,56629,76928,95825,64824,16423,37520,9358,5546,0845,8064,9103,6352,5502,1201,9501,3681,2791,5371,7772,0492,4412,6143,0060004,052
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,941
7,173
7,173
7,173
7,173
56,160
56,254
56,254
56,466
77,289
77,289
77,281
0
0
0
0
0
0000077,28177,28977,28956,46656,25456,25456,1607,1737,1737,1737,1736,941000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,580
1,475
1,396
1,317
1,238
26,842
25,424
24,005
22,585
41,143
39,351
37,559
35,766
33,972
31,734
30,021
11,045
11,04530,02131,73433,97235,76637,55939,35141,14322,58524,00525,42426,8421,2381,3171,3961,4751,580000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
103
235
270
645
749
798
841
802
2,814
0
3,400
10,610
0
0
0
0
000010,6103,40002,8148028417987496452702351030000000000000000
> Total Liabilities 
16,630
0
0
0
60,372
70,482
75,372
15,435
14,665
23,681
26,556
26,586
26,640
23,315
21,367
26,720
25,367
22,143
10,943
18,092
39,982
37,026
36,818
41,956
58,104
60,664
56,625
62,905
118,247
75,224
49,027
38,494
38,49449,02775,224118,24762,90556,62560,66458,10441,95636,81837,02639,98218,09210,94322,14325,36726,72021,36723,31526,64026,58626,55623,68114,66515,43575,37270,48260,37200016,630
   > Total Current Liabilities 
9,364
0
0
0
16,652
26,854
22,427
5,515
4,523
4,714
7,541
7,437
26,305
23,188
19,508
24,782
8,944
7,169
10,730
17,702
21,840
18,659
27,908
33,500
35,884
38,135
33,499
40,194
100,028
58,506
37,175
32,950
32,95037,17558,506100,02840,19433,49938,13535,88433,50027,90818,65921,84017,70210,7307,1698,94424,78219,50823,18826,3057,4377,5414,7144,5235,51522,42726,85416,6520009,364
       Short-term Debt 
587
6,633
0
0
6,730
20,011
14,330
0
0
0
800
953
20,023
16,969
13,938
14,239
562
14,866
0
0
1,766
2,026
2,049
2,072
2,545
2,517
2,293
2,462
72,238
31,539
21,764
17,172
17,17221,76431,53972,2382,4622,2932,5172,5452,0722,0492,0261,7660014,86656214,23913,93816,96920,02395380000014,33020,0116,730006,633587
       Short Long Term Debt 
587
6,633
0
0
6,730
6,681
23,286
0
0
0
800
953
20,085
16,969
13,938
14,239
0
0
0
0
0
0
0
0
0
0
0
0
69,803
29,080
19,359
14,953
14,95319,35929,08069,80300000000000014,23913,93816,96920,08595380000023,2866,6816,730006,633587
       Accounts payable 
792
0
0
0
2,303
936
1,752
2,364
1,352
871
3,618
2,634
2,699
3,176
2,850
5,665
2,930
2,209
3,745
7,875
9,696
6,590
7,695
9,407
12,534
15,780
11,912
15,369
10,384
9,844
8,734
8,700
8,7008,7349,84410,38415,36911,91215,78012,5349,4077,6956,5909,6967,8753,7452,2092,9305,6652,8503,1762,6992,6343,6188711,3522,3641,7529362,303000792
       Other Current Liabilities 
7,985
0
0
0
7,408
5,741
6,104
2,815
2,900
3,629
2,702
3,432
3,225
2,725
2,431
4,466
5,037
4,659
6,540
9,416
9,694
7,957
16,911
21,039
19,934
18,711
18,299
21,535
15,507
15,037
4,465
6,070
6,0704,46515,03715,50721,53518,29918,71119,93421,03916,9117,9579,6949,4166,5404,6595,0374,4662,4312,7253,2253,4322,7023,6292,9002,8156,1045,7417,4080007,985
   > Long-term Liabilities 
0
0
0
0
43,720
43,628
52,945
9,920
10,142
18,968
19,015
19,149
335
127
1,859
1,938
16,423
14,974
213
390
18,142
18,367
8,910
8,456
22,220
22,529
23,126
22,711
18,219
16,718
11,852
5,544
5,54411,85216,71818,21922,71123,12622,52922,2208,4568,91018,36718,14239021314,97416,4231,9381,85912733519,14919,01518,96810,1429,92052,94543,62843,7200000
       Long term Debt Total 
0
0
0
0
0
0
0
9,008
9,029
18,376
18,622
18,777
0
0
1,775
1,775
16,326
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000016,3261,7751,7750018,77718,62218,3769,0299,0080000000
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,696
11,115
10,756
10,392
11,668
11,172
10,663
10,142
9,610
8,789
8,211
7,500
7,5008,2118,7899,61010,14210,66311,17211,66810,39210,75611,11510,69600000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
767
808
287
174
147
44
127
84
163
0
108
213
390
17,996
18,367
8,910
8,456
22,093
22,529
14,570
14,880
10,890
10,250
5,774
0
05,77410,25010,89014,88014,57022,52922,0938,4568,91018,36717,996390213108016384127441471742878087670000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
145
304
304
0
0
183
0
0
0
98
0
0
0
146
0
0
0
127
0
0
0
0
0
0
0
000000012700014600098000183003043041450000000
> Total Stockholder Equity
-27,259
-27,259
0
0
-50,227
-54,020
-57,278
15,235
10,137
5,870
-1,345
-7,379
3,614
-4,213
5,837
14,676
35,082
362,718
345,866
341,565
337,118
311,185
284,734
281,742
249,398
231,487
214,756
118,999
96,157
82,771
80,337
48,868
48,86880,33782,77196,157118,999214,756231,487249,398281,742284,734311,185337,118341,565345,866362,71835,08214,6765,837-4,2133,614-7,379-1,3455,87010,13715,235-57,278-54,020-50,22700-27,259-27,259
   Common Stock
0
0
0
0
0
0
0
1
1
1
1
1
3
3
9
15
19
28
28
28
29
29
29
30
30
31
3
3
5
6
7
9
9765333130302929292828281915933111110000000
   Retained Earnings -673,100-628,854-612,630-581,208-537,317-424,751-385,839-348,715-310,038-278,229-246,071-216,119-193,170-172,417-153,631-143,684-131,953-121,161-113,087-102,577-94,677-88,279-80,614-72,762-66,351-61,425-58,113-54,266000-30,901
   Capital Surplus 
0
0
0
0
0
0
0
81,585
82,899
86,483
86,933
87,297
106,188
108,871
126,989
146,614
178,747
516,321
518,255
534,823
553,747
558,864
564,852
593,572
599,207
617,960
639,814
0
0
0
0
0
00000639,814617,960599,207593,572564,852558,864553,747534,823518,255516,321178,747146,614126,989108,871106,18887,29786,93386,48382,89981,5850000000
   Treasury Stock00000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
7,960
8,406
8,795
86,624
88,061
62,364
92,632
93,275
112,461
108,871
126,989
146,614
178,747
516,321
518,255
534,823
553,747
558,864
564,852
593,572
599,207
617,960
639,814
656,406
677,337
695,411
709,187
720,425
720,425709,187695,411677,337656,406639,814617,960599,207593,572564,852558,864553,747534,823518,255516,321178,747146,614126,989108,871112,46193,27592,63262,36488,06186,6248,7958,4067,9600000



5.4. Balance Sheets

Currency in USD. All numbers in thousands.




5.5. Cash Flows

Currency in USD. All numbers in thousands.




5.6. Income Statements

Currency in USD. All numbers in thousands.


5.7. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue36,116
Cost of Revenue-26,550
Gross Profit9,5669,566
 
Operating Income (+$)
Gross Profit9,566
Operating Expense-224,811
Operating Income-215,245-215,245
 
Operating Expense (+$)
Research Development54,032
Selling General Administrative93,499
Selling And Marketing Expenses0
Operating Expense224,811147,531
 
Net Interest Income (+$)
Interest Income3,311
Interest Expense-5,119
Other Finance Cost-0
Net Interest Income-1,808
 
Pretax Income (+$)
Operating Income-215,245
Net Interest Income-1,808
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-232,431-198,059
EBIT - interestExpense = -232,431
-232,431
-227,374
Interest Expense5,119
Earnings Before Interest and Taxes (EBIT)-227,312-227,312
Earnings Before Interest and Taxes (EBITDA)-213,604
 
After tax Income (+$)
Income Before Tax-232,431
Tax Provision-62
Net Income From Continuing Ops-232,493-232,493
Net Income-232,493
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses251,361
Total Other Income/Expenses Net-17,1861,808
 

Technical Analysis of Bionano
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Bionano. The general trend of Bionano is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Bionano's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Bionano Genomics Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.2626 < 0.2801 < 0.376.

The bearish price targets are: 0.2.

Tweet this
Bionano Genomics Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Bionano Genomics Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Bionano Genomics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Bionano Genomics Inc. The current macd is -0.02108053.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Bionano price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Bionano. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Bionano price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Bionano Genomics Inc Daily Moving Average Convergence/Divergence (MACD) ChartBionano Genomics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Bionano Genomics Inc. The current adx is 18.82.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Bionano shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Bionano Genomics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Bionano Genomics Inc. The current sar is 0.20320364.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Bionano Genomics Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Bionano Genomics Inc. The current rsi is 40.21. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Bionano Genomics Inc Daily Relative Strength Index (RSI) ChartBionano Genomics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Bionano Genomics Inc. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Bionano price going down in the near term. -2
  • Trending up: The STOCH %K is trending up. +1
Bionano Genomics Inc Daily Stochastic Oscillator ChartBionano Genomics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Bionano Genomics Inc. The current cci is -41.95942659.

Bionano Genomics Inc Daily Commodity Channel Index (CCI) ChartBionano Genomics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Bionano Genomics Inc. The current cmo is -14.19761071.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Bionano Genomics Inc Daily Chande Momentum Oscillator (CMO) ChartBionano Genomics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Bionano Genomics Inc. The current willr is -51.91594561.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Bionano is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Bionano Genomics Inc Daily Williams %R ChartBionano Genomics Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Bionano Genomics Inc.

Bionano Genomics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Bionano Genomics Inc. The current atr is 0.02694591.

Bionano Genomics Inc Daily Average True Range (ATR) ChartBionano Genomics Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Bionano Genomics Inc. The current obv is -122,673,708.

Bionano Genomics Inc Daily On-Balance Volume (OBV) ChartBionano Genomics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Bionano Genomics Inc. The current mfi is 35.52.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Bionano Genomics Inc Daily Money Flow Index (MFI) ChartBionano Genomics Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Bionano Genomics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-31DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-08-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-08-07ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-13RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-08-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-08-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-09-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-10CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-13STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-17STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-09-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-20STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-25STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-09-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-03STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-10-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-17MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-10-29MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-10-31DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-01WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-04CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-14WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-15STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-11-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-11-19MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-22RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-11-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-11-27STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-12-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Bionano Genomics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Bionano Genomics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5040.213
Ma 20Greater thanMa 500.251
Ma 50Greater thanMa 1000.317
Ma 100Greater thanMa 2000.412
OpenGreater thanClose0.245
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Bionano with someone you think should read this too:
  • Are you bullish or bearish on Bionano? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Bionano? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community